Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.323
-0.007 (-2.09%)
Mar 25, 2025, 4:00 PM EDT - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $13.34 million as of March 26, 2025. Its market cap has decreased by -93.59% in one year.
Market Cap
13.34M
Enterprise Value
-43.48M
1-Year Change
-93.59%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $13.34M, a decrease of -96.01%. That is a compound annual growth rate of -51.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 13.34M | -23.10% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 68.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 776.83B |
| UnitedHealth Group | 472.45B |
| Johnson & Johnson | 393.50B |
| AbbVie | 369.26B |
| Novo Nordisk | 335.17B |
| Merck & Co. | 233.18B |
| AstraZeneca | 229.25B |
| Abbott Laboratories | 220.62B |